Immatics (IMTX) EBT Margin Growth (1y) (2020 - 2025)
Immatics (IMTX) EBT Margin Growth (1y) (2020 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-1,532.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,558.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Immatics |
14.67 Bn |
14.67 Bn |
- |
-31,070.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
-31,070.00 |
| Sep 30, 2025 |
-96,570.00 |
| Jun 30, 2025 |
-141,102.00 |
| Mar 31, 2025 |
-21,414.00 |
| Dec 31, 2024 |
29,496.00 |
| Sep 30, 2024 |
43,579.00 |
| Jun 30, 2024 |
1,491.00 |
| Mar 31, 2024 |
19,589.00 |
| Dec 31, 2023 |
-13,658.00 |
| Sep 30, 2023 |
-31,169.00 |
| Jun 30, 2023 |
-3,554.00 |
| Mar 31, 2023 |
-28,482.00 |
| Dec 31, 2022 |
7,908.00 |
| Sep 30, 2022 |
28,690.00 |
| Jun 30, 2022 |
43,679.00 |
| Mar 31, 2022 |
39,140.00 |
| Dec 31, 2021 |
8,350.00 |
| Sep 30, 2021 |
166,083.00 |
| Jun 30, 2021 |
-20,210.00 |
| Mar 31, 2021 |
-18,628.00 |
